Publications by authors named "Jennifer Osborn"

Claim this Profile
A
A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications.
Bailey McCarville, Jennifer Osborn

Hosp Pharm· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment Centers.
Nausheen Ahmed, Fang Sun, Christie Teigland, Karl M Kilgore, Iman Mohammadi, Jennifer Osborn

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.
Audrey Rachlin, Lee M Hampton, Paul A Rota, Mick N Mulders, Mark Papania, Jennifer Osborn

Vaccines (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel Fluorescent-Based Lateral Flow Assay for the Detection of Neisseria gonorrhoeae at the Point of Care.
Birgitta Gleeson, Jeremie Piton, Laura Mazzola, Sean McHugh, Jillian Bender, Jennifer Osborn

Sex Transm Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test.
Arjun Chandna, Raman Mahajan, Priyanka Gautam, Lazaro Mwandigha, Sabine Dittrich, Jennifer Osborn

PLOS Glob Public Health· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.
Arjun Chandna, Raman Mahajan, Priyanka Gautam, Lazaro Mwandigha, Karthik Gunasekaran, Jennifer Osborn

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticipating the future: prognostic tools as a complementary strategy to improve care for patients with febrile illnesses in resource-limited settings.
Arjun Chandna, Jennifer Osborn, Quique Bassat, David Bell, Sakib Burza

BMJ Glob Health· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.
Cecilia Ferreyra, Jennifer Osborn, Francis Moussy, Emilie Alirol, Monica Lahra

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping.
Julia A Shlensky, Kristina M Thurber, John G O'Meara, Narith N Ou, Jennifer L Osborn

Vasc Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countries.
Jennifer Osborn, Teri Roberts, Ethan Guillen, Oscar Bernal, Paul Roddy

BMC Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of In-Hospital Bleeding and Cardiovascular Events with High-Dose Bolus Tirofiban and Shortened Infusion to Short-Duration Eptifibatide as Adjunctive Therapy for Percutaneous Coronary Intervention.
Gabrielle L Anderson, Jennifer L Osborn, Scott D Nei, Malcolm R Bell, Gregory W Barsness

Am J Cardiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining System Requirements for Simplified Blood Culture to Enable Widespread Use in Resource-Limited Settings.
Peter J Dailey, Jennifer Osborn, Elizabeth A Ashley, Ellen Jo Baron, David A B Dance

Diagnostics (Basel)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Diuresis After Colon and Rectal Surgery Does Not Reduce Length of Hospital Stay: Results of a Randomized Trial.
Ilya M Danelich, John R Bergquist, Whitney J Bergquist, Jennifer L Osborn, Sampaguita S Wright

Dis Colon Rectum· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assays for estimating HIV incidence: updated global market assessment and estimated economic value.
Charles S Morrison, Rick Homan, Natasha Mack, Pairin Seepolmuang, Megan Averill, Jennifer Osborn

J Int AIDS Soc· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1.
Jered Singleton, Jennifer L Osborn, Lorraine Lillis, Kenneth Hawkins, Dylan Guelig

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Protocol Review Scenario: Justify, justify, justify.
Jennifer Osborn, Rebecca K Holt

Lab Anim (NY)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rapid, Multiplexed, High-Throughput Flow-Through Membrane Immunoassay: A Convenient Alternative to ELISA.
Sujatha Ramachandran, Mitra Singhal, Katherine G McKenzie, Jennifer L Osborn, Amit Arjyal

Diagnostics (Basel)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress toward multiplexed sample-to-result detection in low resource settings using microfluidic immunoassay cards.
Lisa Lafleur, Dean Stevens, Katherine McKenzie, Sujatha Ramachandran, Paolo Spicar-Mihalic, Jennifer Osborn

Lab Chip· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidics without pumps: reinventing the T-sensor and H-filter in paper networks.
Jennifer L Osborn, Barry Lutz, Elain Fu, Peter Kauffman, Dean Y Stevens

Lab Chip· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enabling a microfluidic immunoassay for the developing world by integration of on-card dry reagent storage.
Dean Y Stevens, Camille R Petri, Jennifer L Osborn, Paolo Spicar-Mihalic, Katherine G McKenzie

Lab Chip· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.
Samuel A Jacobs, Steven H Swerdlow, Jeffrey Kant, Kenneth A Foon, Rachel Jankowitz, Jennifer L Osborn

Clin Cancer Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct multiplexed measurement of gene expression with color-coded probe pairs.
Gary K Geiss, Roger E Bumgarner, Brian Birditt, Timothy Dahl, Naeem Dowidar, Jennifer L Osborn

Nat Biotechnol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis